Background and Purpose: Excitatory amino acids and their receptors are involved in mediating ischemic neuronal damage. The cr-agonists are believed to interact with the iV-methyl-D-aspartate receptor. Therefore, we studied the neuroprotective, hypothermic, and motor deficit effects of the cr-agonist SKF 10,047 and the JV-methyl-D-aspartate antagonist MK-801.
-1422 - 24 We have recently reported that the prototypical o--agonist SKF 10,047 (7V-aHylnormetazocine) was neuroprotective against the excitotoxic action of glutamate in an in vitro ischemia model system of cultured rat cerebellar granule cells. 25 This type of neuroprotection has been seen in other in vitro model systems as well. 13 - 22 The compounds (-t-)SKF 10,047 and MK-801 are thought to be neuroprotective by acting as noncompetitive antagonists at the NMDA receptor channel, blocking cation influx initiated by the excitatory amino acids glutamate and aspartate. 1 -5 However, (+)SKF 10,047 also binds with higher affinity to a haloperidol-sensitive o--site, which is better defined by the more specific <r-ligands (+)-3-PPP [3-(3-hydroxyphenyl)-AT-(l-propyl)piperidine] and DTG (1,3-di-orthotolyl-guanidine). 26 - 27 This a-site 3 -4 -24 has little affinity for MK-801, yet animals trained to recognize MK-801 also recognize (+)SKF 10,047 in drug discrimination studies (cross-generalizing) through interactions at the PCP s j t e 18, 24, 28 The higher affinity <r-site is thought not to play a role in (+)SKF 10,047 discrimination. 24 - 28 Because of the complex pharmacology of these drug interactions, recently dubbed "the sigma enigma," 29 we decided to compare the neuroprotective effects of SKF 10,047 and MK-801 in our in vitro cell culture system and in the gerbil model of global brain ischemia. 
Materials and Methods
Primary cultures of rat cerebellar neurons were prepared from 8-day-old Sprague-Dawley rat pups (Taconic Farms, Germantown, N.Y.) and used after 8 or 9 days in culture for neuroprotection studies as previously described. 1214 This in vitro ischemia model differs from other models of glucose deprivation or hypoxia 1315 by demonstrating rapid (30-minute) excitotoxicity by exogenous glutamate through the NMDA receptor 14 and emphasizes an enhanced response to low concentrations of agonist once the voltage-dependent Mg 2 * block is removed as a result of energy depletion.
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The Mongolian gerbil model of global forebrain ischemic stroke has been extensively studied and characterized. 6 -732 - 35 In brief, male Mongolian gerbils weighing 60-70 g (Tumblebrook Farms, West Brookfield, Mass.) were anesthetized with 2.5% isoflurane in a mixture with 100% O 2 , placed onto a heating pad to maintain body temperature at 37°C, exposed to a 5-minute bilateral carotid occlusion, and allowed to recover on the heating pad for 10 minutes. At appropriate times, bilateral neuronal counts over a 750 -/im section of the hippocampal CA1 regions stained in 0.1% Thionin were determined by microscopic examination of coded slides.
Untreated, conscious gerbils were injected with either 60 mg/kg s.c. (+)SKF 10,047 or 3 mg/kg i.p. MK-801 and compared with saline-injected animals for motor function over time as monitored by a swing grid test, which is an adaptation of the inclined plane test. 36 In brief, gerbils were placed onto a 5 x 7-inch metal mesh grid held horizontally. The grid was rotated 180° about a fixed axis, starting in a downward direction, over a 2-second interval. The number of degrees at which the animal lost its grip was recorded. Results were expressed as the number of degrees needed to complete 180°; this value was 0° for untreated animals able to hold on to the grid while upside down.
The rectal temperature of gerbils was monitored with a RET-3 rectal probe for mice. Temporalis muscle temperature was measured with a TYPE MT-29/2 hypodermic needle microprobe attached to a Sensortek TH-8 Temperature Monitor (Physitemp Instruments, Inc., Clifton, N.J.).
The enantiomers of SKF 10,047 were either obtained through the National Institute on Drug Abuse, Rockville, Md., or purchased from Research Biochemicals, Inc., Natick, Mass., which was also the source of the enantiomers of MK-801. Cyclazocine and pentazocine were obtained as racemic mixtures from in-house supplies.
Data in text and figures are mean±SEM values of the indicated number of experiments. Comparisons between treatment groups and vehicle were analyzed with the most rigorous tests applicable to each pool of data and are specified in the figure legends. Significant difference was accepted at p<0.05, and probability values for each data set were calculated. Figure 1 shows the protective effects of the enantiomers of MK-801 and SKF 10,047 along with two related benzomorphans that act at the NMDA receptor. 37 The data from our previous study 25 Three or 7 days after 5-minute ischemia, there was 86% or 71% respective protection of CA1 neurons when (+)SKF 10,047 was given 15 minutes before occlusion at 60 mg/kg but not at 30 mg/kg (Figures 2 and 3) . A variation of the treatment regimen is also shown in Figure 3 , where administering (+)SKF 10,047 as a bolus of 15 mg/kg at 15 minutes and 1 hour after reperfusion followed by 30 mg/kg at 2, 4, and 6 hours after ischemia was nearly as effective (61% protection, p=0.03) as a single 60-mg/kg pretreatment dose. However, there was no protective effect when (+)SKF 10,047 was given as a single 60-mg/kg dose 30 minutes after reperfusion.
Results
Previously, MK-801 had been found to be optimally neuroprotective at a dose of 3 mg/kg when administered by intraperitoneal injection. 6 -9 Our results using this treatment regimen show that pretreatment with MK-801 at 3 mg/kg given 1 hour before occlusion gave 82% or 64% protection of CA1 hippocampal neurons 3 or 7 days after ischemia ( Figure 4) ; MK-801 at 10 mg/kg (85%) was statistically no more protective than at 3 mg/kg 7 days after reperfusion ( Figure 4) .
We tested the hypothermic effects of 3 mg/kg MK-801 on conscious gerbils to avoid anesthetic or surgical effects on temperature 32 " 35 and monitored both rectal and temporalis muscle temperatures, the latter as a reliable indirect estimate of brain temperature 38 ( Figure 5 
is indicated over each bar. Analysis was by two-factor analysis of variance; comparisons between treatments were performed with a two-factor repeated-measures design. Significant protection as compared with vehicletreated gerbils is indicated over each bar. A between-groups comparison (by Kruskal-Wallis procedure), analyzed as percentage of vehicle, found no significant difference between 3 and 10 mg/kg at 7 days (p=0.44).
temperature of ischemic gerbils receiving (+)SKF 10,047 and found no significant decrease in temperature within the assumed 45-minute therapeutic window of opportunity 35 ( Figure 6 ). Significant changes from baseline temperatures after 4 hours of treatment were resolved by 30 minutes.
As seen in Figure 7 , normal, conscious gerbils receiving an equally neuroprotective dose of each drug were ataxic within as early as 15 minutes and were unable to hold on to the grid. (+)SKF 10,047-treated gerbils had 50% return of function by 2 hours and showed no further differences. In contrast, animals given MK-801 were severely disabled for 8 hours (Figure 7) . Return of motor function for the MK-801 test group was apparent by 13 hours but was still significantly different from salinetreated animals (^=0.0002). By analyzing the time required for 50% recovery (TV2), we calculated a TV2 of 2 hours for (+)SKF 10,047 and a T1/2 of 11 hours for MK-801, establishing a 5.5 ratio of motor impairment.
Discussion
The relative order of potency of the drugs tested in our cerebellar granule cell model of in vitro ischemia was the same as that defined by inhibition of [ 3 H]MK-801 binding to rat brain membranes. 424 Our in vitro neuroprotection results are most likely a reflection of drug interaction at the NMDA receptor to prevent glutamate-induced excitotoxicity.
12142530 - 31 The same antagonist order of potency has also been seen for neuroprotection of cortical neurons exposed to NMDA or hypoxia, 13 for blocking NMDA excitotoxicity in ex vivo chick embryo retina, 2239 for inhibition of NMDA modulation of muscarinic-stimulated phosphoinositide hydrolysis in rat cortical slices, 11 and for ability to reduce NMDA-evoked and spontaneous epileptiform activity of neocortical slices. 40 The 10-fold protective difference that we saw between ±cyclazocine and ±pentazocine mirrors their differential potency as antagonists of JV-methylaspartate-evoked excitations of spinal neurons. 37 It is likely that the in vitro data are predictive of activity in vivo, in which only twenty times more (+)SKF 10,047 was needed to achieve comparable neuroprotection in the gerbil model of global brain ischemia. This is an underestimation of comparable efficacy because subcutaneous administration of (+)SKF 10,047 is likely to result in slower absorption than intraperitoneal administration of MK-801.
The protective actions of MK-801 in reducing neuronal damage in gerbils exposed to 5 minutes of cerebral ischemia have been recently attributed solely to its hypothermic effect. 3334 In those studies, MK-801 failed Figure  3 ( to protect against hippocampal cell loss or spatial memory impairment when treated animals were maintained as normothermic during and after ischemia. Busto et al 38 showed in the rat four-vessel occlusion model that simply lowering brain temperature by only two degrees prevented ischemic damage to neurons. has proven beneficial to different brain regions in rat 41 and gerbil models of global brain ischemia, in which a critical period for reversing CA1 injury was identified as being between 15 and 45 minutes after reperfusion. 35 To attempt to separate the MK-801-induced hypothermic effect from the decrease in body temperature resulting from anesthesia, surgery, and the resulting inactivity, we looked at direct temperature effects in conscious animals and still saw an immediate 1-to 2-degree hypothermic effect, which has been shown to enhance the MK-801 protective effect. 42 Because brain hypothermia induced by (+)SKF 10,047 was significant only after 4 hours in animals given a neuroprotective regimen, the therapeutic effect seems independent of hypothermia, considering that the window of vulnerability is within the first hour of reperfusion. 35 Some investigators have agreed that the MK-801-induced hypothermia is responsible for only 30% of its neuroprotective action, which corroborates earlier findings. 42 A sustained dosage may be more important: 60 mg/kg (+)SKF 10,047 did not protect when given 30 minutes after reperfusion, yet produces 2° hypothermia in 15 minutes.
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FIGURE 6. Changes in temporalis muscle and rectal temperatures in ischemic gerbils treated with (+)SKF 10,047. Temperature was monitored at selected time intervals before, during, and after anesthesia, ischemia, and reperfusion in gerbils receiving either vehicle (n=10) or (+)SKF 10,047 (n=6) administered as the multiple dosing regimen in
A case has been made for the clinical use of NMDA antagonists to treat ischemic brain injury, with appropriate cautions and safety issues considered. 43 The potential usefulness of NMDA antagonists and <r-compounds for specific, acute disorders such as stroke, cardiac arrest, or neurotrauma may dispel the concerns over dysphoria or psychotomimetic side effects, especially for acute, limited treatment. Regarding the side effects of benzomorphan cr-ligands, it is imperative to reiterate that their dysphoric and psychotomimetic effects in humans reside in the levorotatory enantiomer (as reviewed in reference 44). Despite the animal discrimination studies that link MK-801 and (+)SKF 10,047 behaviorally, 182428 (+)SKF 10,047 has been shown to produce unique changes in encephalographic spectral parameters that are distinctly different from those produced by PCP or MK-801. 45 Such differences may be related to the distinctly faster recovery from motor deficits induced by (+)SKF 10,047 versus MK-801, as shown in the present study.
Thus, the mode of action of drugs that cross-react at both PCP and cr-sites may never be well defined by either behavioral or binding studies, as we have suggested previously. 25 By studying neuroprotection, we hope to bypass some of the confusion and contradictions encountered when investigating these interesting classes of compounds, which may be neuroprotective by simply inducing hypothermia. 3334 We recognize that separate PCP/MK-801, dextromethorphan, and tr-sites may coexist within the NMDA channel and that there may be utility in using a ligand as cross-reactive as (-t-)SKF 10,047. 232546 The neuroprotection studies reported here are an indication that this class of compound may prove useful in the treatment of cerebral ischemia and stroke.
